Notification of major holdings - Pentwater

Summary by AI BETAClose X

Pentwater Capital Management LP has notified Ondine Biomedical Inc. of a change in its major holdings, crossing a threshold due to an acquisition or disposal of financial instruments and an event changing the breakdown of shares outstanding. As of May 5, 2026, Pentwater Capital Management LP holds a total of 4.053088% of Ondine Biomedical Inc.'s shares outstanding, an increase from its previous notification of 3.993187%. The total number of shares outstanding held by the issuer is 22,746,666.00.

Disclaimer*

UK 100

Latest directors dealings